Sandbox:Mitra: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 |B01=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Reperfusion]]'''|B02=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Maintenance of [[RV]] [[preload]]'''|B03=<div style="float: center; text-align: center; width: 5em; padding:1em;">'''Decreasing [[RV]] [[afterload]]'''|B04=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Restoring [[Rate]]/[[Rhythm]] and [[AV synchrony]]'''|B05=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Inotropic support'''|B06=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Mechanical Circulatory Support]]'''}}
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 |B01=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Reperfusion]]'''|B02=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Maintenance of [[RV]] [[preload]]'''|B03=<div style="float: center; text-align: center; width: 5em; padding:1em;">'''Decreasing [[RV]] [[afterload]]'''|B04=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Restoring [[Rate]]/[[Rhythm]] and [[AV synchrony]]'''|B05=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Inotropic support'''|B06=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Mechanical Circulatory Support]]'''}}
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | |}}
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | |}}
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | | C06 |C01=<div style="float: Center; text-align: Center; width: 5em; padding:2em;"> '''[[Thrmobolytics]]''' <br> '''[[Percutaneous coronary intervention]] ([[PCI]])''' <br>
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | | C06 |C01=<div style="float: Center; text-align: Center; width: 5em; padding:3em;">'''[[Thrmobolytics]]''' <br>'''[[Percutaneous coronary intervention]] ([[PCI]])''' <br>
|C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload-reducing agents''', such as:<br>
|C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload-reducing agents''', such as:<br>
:❑ [[Nitrates]]  
:❑ [[Nitrates]]  

Revision as of 01:52, 6 August 2020



 
 
 
 
 
 
 
 
 
 
 
 
Therapuetic Considerations in Right Ventriculay Myocardial Infarction (RVMI)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maintenance of RV preload
 
 
Decreasing RV afterload
 
Restoring Rate/Rhythm and AV synchrony
 
Inotropic support
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Avoidance of preload-reducing agents, such as:
Nitrates
Diuretics
Morphin

In patients with hypotension (without pulmonary congestion):

❑ Intravenous administration of Fluids (N/S 0.9% at 40mL/min for up to 2L, to maintain CVP <15 mmHg and PCWP between 18-24 mmHg)
 
 
Systemic or pulmonary vasodilators:
Nitrosrusside
❑ Inhaled nitric oxide
 
In patients with bradyarrhthmias:
Atropine
Pacemaker

In patients with atrioventricular block:

❑ Temporary dual-chamber pacemaker
 
In patients with refractory hypotension:
Dobutamine (along with fluids)
❑ Other inotropes:
 
 
May be needed in patients with cardiogenic shock secondary to RVMI:
❑ Direct RV support
❑ Indirect RV support
❑ Biventricular support




Do's

Don'ts





Previously:



Consider right ventricular MI in case of:

Hypotension
❑ Elevated jugular venous pressure
❑ Clear lung fields
ECG changes suggestive of an inferior MI

❑ ST elevation in leads II, III and aVF
 
 
 
 
 
Order a right sided ECG in all patients with ST elevation in leads II, III and aVF

❑ Clearly label the ECG as right sided to minimize confusion in the emergency room and cath lab

❑ ST-segment elevation of >1 mm in lead V4R suggests a right ventricular MI
 
 
 
 
 

❑ Do not delay the decision and initiation of PCI vs fibrinolytic therapy
❑ Do not administer:

Beta blockers
Nitrates
Diuretics

❑ Increase the right ventricle load by volume expansion with normal saline preferably with invasive monitoring

❑ If central hemodynamic monitoring is available, administer normal saline (40 ml/min, up to a total of 2 L, intravenously) until there is an increase in the pulmonary capillary wedge pressure to approximately 15 mmHg [1]
❑ If central hemodynamic monitoring in not available, administer normal saline with a close monitoring of the blood pressure
 
 
 
 
 
If hypotension is not corrected with 1-2 L normal saline:

❑ Administer inotropic agents

❑  Norepinephrine
❑  Initial dose: 0.5–1.0 μg/min
❑  Maximum dose: 30–40 μg/min
❑  Titrate to SBP >90 mm Hg
❑  Dopamine
❑  Cardiac dose: 5.0–10 μg/kg/min
❑  Pressor dose: 10–20 μg/kg/min
❑  Maximum dose: 20–50 μg/kg/min
❑  Dobutamine
❑  Usual dose: 2.0–20 μg/kg/min
❑  Maximum dose: 40 μg/kg/min
❑  Avoid ↑ HR by >10% of baseline
❑  Milrinone
❑  Loading dose: 50 μg/kg (slowly over 10 minutes)
❑  Maintenance dose: 0.375–0.75 μg/kg/min

❑ Initiate hemodynamic monitoring with a pulmonary catheter if possible

  1. Inohara T, Kohsaka S, Fukuda K, Menon V (2013). "The challenges in the management of right ventricular infarction". Eur Heart J Acute Cardiovasc Care. 2 (3): 226–34. doi:10.1177/2048872613490122. PMC 3821821. PMID 24222834.